ID   DAPK2_MOUSE             Reviewed;         370 AA.
AC   Q8VDF3; O88861; Q9QYM4;
DT   28-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Death-associated protein kinase 2;
DE            Short=DAP kinase 2;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9UIK4};
DE   AltName: Full=DAP-kinase-related protein 1;
DE            Short=DRP-1;
GN   Name=Dapk2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000312|EMBL:AAH22165.1};
RN   [1] {ECO:0000312|EMBL:BAA88064.1}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10376525; DOI=10.1038/sj.onc.1202701;
RA   Kawai T., Nomura F., Hoshino K., Copeland N.G., Gilbert D.J., Jenkins N.A.,
RA   Akira S.;
RT   "Death-associated protein kinase 2 is a new calcium/calmodulin-dependent
RT   protein kinase that signals apoptosis through its catalytic activity.";
RL   Oncogene 18:3471-3480(1999).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 68-370.
RX   PubMed=10629061; DOI=10.1128/mcb.20.3.1044-1054.2000;
RA   Inbal B., Shani G., Cohen O., Kissil J.L., Kimchi A.;
RT   "Death-associated protein kinase-related protein 1, a novel
RT   serine/threonine kinase involved in apoptosis.";
RL   Mol. Cell. Biol. 20:1044-1054(2000).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299 AND SER-349, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299 AND SER-349, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung,
RC   Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ALTERNATIVE SPLICING (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=21408167; DOI=10.1371/journal.pone.0017344;
RA   Shoval Y., Berissi H., Kimchi A., Pietrokovski S.;
RT   "New modularity of DAP-kinases: alternative splicing of the DRP-1 gene
RT   produces a ZIPk-like isoform.";
RL   PLoS ONE 6:E17344-E17344(2011).
RN   [7]
RP   INTERACTION WITH 14-3-3 PROTEINS.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with 14-3-
RT   3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 11-370 IN COMPLEX WITH AMP AND
RP   ATP, SUBUNIT, ACTIVITY REGULATION, AND AUTOINHIBITORY DOMAIN.
RX   PubMed=21497605; DOI=10.1016/j.jmb.2011.03.065;
RA   Patel A.K., Yadav R.P., Majava V., Kursula I., Kursula P.;
RT   "Structure of the dimeric autoinhibited conformation of DAPK2, a pro-
RT   apoptotic protein kinase.";
RL   J. Mol. Biol. 409:369-383(2011).
RN   [9]
RP   DISRUPTION PHENOTYPE, AND TISSUE SPECIFICITY.
RX   PubMed=24906443; DOI=10.1186/1756-0500-7-345;
RA   Guay J.A., Wojchowski D.M., Fang J., Oxburgh L.;
RT   "Death associated protein kinase 2 is expressed in cortical interstitial
RT   cells of the mouse kidney.";
RL   BMC Res. Notes 7:345-345(2014).
RN   [10]
RP   FUNCTION.
RX   PubMed=24163421; DOI=10.1189/jlb.0813462;
RA   Geering B., Stoeckle C., Rozman S., Oberson K., Benarafa C., Simon H.U.;
RT   "DAPK2 positively regulates motility of neutrophils and eosinophils in
RT   response to intermediary chemoattractants.";
RL   J. Leukoc. Biol. 95:293-303(2014).
CC   -!- FUNCTION: Calcium/calmodulin-dependent serine/threonine kinase involved
CC       in multiple cellular signaling pathways that trigger cell survival,
CC       apoptosis, and autophagy. Capable of regulating both type I apoptotic
CC       and type II autophagic cell death signals. The former involves caspase
CC       activation, chromatin and mitochondrial condensation while the latter
CC       involves caspase-independent cell death in conjunction with
CC       accumulation of mature autophagic vesicles, plasma membrane blebs, and
CC       nuclear condensation without DNA degradation. Mediator of anoikis and a
CC       suppressor of beta-catenin-dependent anchorage-independent growth of
CC       malignant epithelial cells. May play a role in granulocytic maturation
CC       (By similarity). Regulates granulocytes motility by controlling cell
CC       spreading and polarization (PubMed:24163421).
CC       {ECO:0000250|UniProtKB:Q9UIK4, ECO:0000269|PubMed:24163421}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9UIK4};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9UIK4};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P53355};
CC   -!- ACTIVITY REGULATION: Activated by Ca(2+)/calmodulin. Regulated by a
CC       double locking mechanism, involving autophosphorylation at Ser-318,
CC       calmodulin binding, and dimerization. In the inactive state, Ser-318 is
CC       phosphorylated, and the kinase is dimeric. Activation involves:
CC       dephosphorylation at Ser-318, release-of-autoinhibition mechanism where
CC       calmodulin binding induces a conformational change that relieves the
CC       steric block of the active site by the autoinhibitory domain, and
CC       generation of the monomeric active form of the kinase.
CC       {ECO:0000269|PubMed:21497605}.
CC   -!- SUBUNIT: Homodimer in its autoinhibited state. Active as monomer.
CC       Interacts with 14-3-3 proteins YWHAB, YWHAE, YWHAG, YWHAH, YWHAQ, YWHAZ
CC       and SFN; the interaction requires DAPK2 phosphorylation at Thr-369 and
CC       suppresses DAPK2 kinase activity and DAPK2-induced apoptosis.
CC       {ECO:0000269|PubMed:21497605, ECO:0000269|PubMed:26047703}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasmic vesicle,
CC       autophagosome lumen {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q8VDF3-1; Sequence=Displayed;
CC       Name=2; Synonyms=Beta;
CC         IsoId=Q8VDF3-2; Sequence=VSP_042058;
CC   -!- TISSUE SPECIFICITY: Expressed in peritubular interstitial cells of the
CC       renal cortex (PubMed:24906443). Isoform 1 is found in the adult brain
CC       while isoform 2 is expressed in brains of embryos and young mice (at
CC       protein level) (PubMed:21408167). {ECO:0000269|PubMed:21408167,
CC       ECO:0000269|PubMed:24906443}.
CC   -!- DOMAIN: The autoinhibitory domain sterically blocks the substrate
CC       peptide-binding site by making both hydrophobic and electrostatic
CC       contacts with the kinase core.
CC   -!- PTM: Autophosphorylation at Ser-318 inhibits its catalytic activity.
CC       Dephosphorylated at Ser-318 in response to activated Fas and TNF-alpha
CC       receptors. {ECO:0000250|UniProtKB:Q9UIK4}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype.
CC       {ECO:0000269|PubMed:24906443}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. DAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB018002; BAA88064.1; -; mRNA.
DR   EMBL; BC022165; AAH22165.1; -; mRNA.
DR   EMBL; AF052942; AAC35002.1; -; mRNA.
DR   CCDS; CCDS23303.1; -. [Q8VDF3-1]
DR   RefSeq; NP_034149.2; NM_010019.3. [Q8VDF3-1]
DR   PDB; 2YA9; X-ray; 2.30 A; A/B=11-370.
DR   PDB; 2YAA; X-ray; 2.30 A; A/B=11-370.
DR   PDB; 2YAB; X-ray; 1.90 A; A/B=11-370.
DR   PDBsum; 2YA9; -.
DR   PDBsum; 2YAA; -.
DR   PDBsum; 2YAB; -.
DR   AlphaFoldDB; Q8VDF3; -.
DR   SMR; Q8VDF3; -.
DR   BioGRID; 199051; 1.
DR   STRING; 10090.ENSMUSP00000034944; -.
DR   iPTMnet; Q8VDF3; -.
DR   PhosphoSitePlus; Q8VDF3; -.
DR   EPD; Q8VDF3; -.
DR   MaxQB; Q8VDF3; -.
DR   PaxDb; Q8VDF3; -.
DR   PRIDE; Q8VDF3; -.
DR   ProteomicsDB; 279821; -. [Q8VDF3-1]
DR   ProteomicsDB; 279822; -. [Q8VDF3-2]
DR   Antibodypedia; 13340; 633 antibodies from 42 providers.
DR   DNASU; 13143; -.
DR   Ensembl; ENSMUST00000034944; ENSMUSP00000034944; ENSMUSG00000032380. [Q8VDF3-1]
DR   GeneID; 13143; -.
DR   KEGG; mmu:13143; -.
DR   UCSC; uc009qen.2; mouse. [Q8VDF3-1]
DR   CTD; 23604; -.
DR   MGI; MGI:1341297; Dapk2.
DR   VEuPathDB; HostDB:ENSMUSG00000032380; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000153424; -.
DR   HOGENOM; CLU_000288_63_0_1; -.
DR   InParanoid; Q8VDF3; -.
DR   OMA; NLRNCES; -.
DR   OrthoDB; 813445at2759; -.
DR   PhylomeDB; Q8VDF3; -.
DR   TreeFam; TF314166; -.
DR   BioGRID-ORCS; 13143; 1 hit in 76 CRISPR screens.
DR   EvolutionaryTrace; Q8VDF3; -.
DR   PRO; PR:Q8VDF3; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q8VDF3; protein.
DR   Bgee; ENSMUSG00000032380; Expressed in hindlimb stylopod muscle and 164 other tissues.
DR   ExpressionAtlas; Q8VDF3; baseline and differential.
DR   Genevisible; Q8VDF3; MM.
DR   GO; GO:0034423; C:autophagosome lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0043276; P:anoikis; ISO:MGI.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:1990266; P:neutrophil migration; IMP:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IBA:GO_Central.
DR   GO; GO:2000424; P:positive regulation of eosinophil chemotaxis; ISO:MGI.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISO:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:2001242; P:regulation of intrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Calmodulin-binding; Cytoplasm; Cytoplasmic vesicle; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..370
FT                   /note="Death-associated protein kinase 2"
FT                   /id="PRO_0000085913"
FT   DOMAIN          23..285
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          287..354
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          292..301
FT                   /note="Autoinhibitory domain"
FT   ACT_SITE        149
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         29..37
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:21497605"
FT   BINDING         52
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:21497605"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         318
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UIK4"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         369
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UIK4"
FT   VAR_SEQ         286..370
FT                   /note="TPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRSLMKKVH
FT                   LRTSEDLRNCESDTEENIARRKALHPRRRSSTS -> SKGEARAPEQWKAQPAQLKTKR
FT                   LREYTLKCHSSMPPNNTYVNFERFAHVVEDVARVDKGCRALAGAHDTLQDDVESLVSIY
FT                   NEKEAWYREENENARHNLSQLKYEYRKVESLKKLLREDIQATGASLGGVARKLDHLQAQ
FT                   FETLRQQLSADIQWMQELVGIFQLESENTDSHSLGFMFHRDPSESLSELLNRSHAEEVL
FT                   AGLSL (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042058"
FT   CONFLICT        89
FT                   /note="L -> R (in Ref. 3; AAC35002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        90
FT                   /note="H -> Q (in Ref. 1; BAA88064)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        270
FT                   /note="T -> P (in Ref. 3; AAC35002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        341
FT                   /note="S -> I (in Ref. 3; AAC35002)"
FT                   /evidence="ECO:0000305"
FT   HELIX           19..21
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          23..32
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          35..42
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   TURN            43..45
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          48..56
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          59..61
FT                   /evidence="ECO:0007829|PDB:2YA9"
FT   STRAND          63..66
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           68..78
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          89..94
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          96..104
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           111..115
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           123..142
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           152..154
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          155..158
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          162..164
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   STRAND          167..169
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           191..193
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           196..199
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           207..222
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           232..240
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           248..251
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           256..265
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   TURN            270..272
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           276..280
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   TURN            283..285
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           290..297
FT                   /evidence="ECO:0007829|PDB:2YAB"
FT   HELIX           303..309
FT                   /evidence="ECO:0007829|PDB:2YAB"
SQ   SEQUENCE   370 AA;  42778 MW;  7BF8577140B5F883 CRC64;
     MVQASMRSPN METFKQQKVE DFYDIGEELG SGQFAIVKKC REKSTGLEYA AKFIKKRQSR
     ASRRGVCREE IEREVSILRQ VLHPNIITLH DVYENRTDVV LILELVSGGE LFDFLAQKES
     LSEEEATSFI KQILDGVNYL HTKKIAHFDL KPENIMLLDK NIPIPHIKLI DFGLAHEIED
     GVEFKNIFGT PEFVAPEIVN YEPLGLEADM WSIGVITYIL LSGASPFLGD TKQETLANIT
     AVSYDFDEEF FSQTSELAKD FIRKLLVKET RKRLTIQEAL RHPWITPVDT QQAMVRRESV
     VNLENFKKQY VRRRWKLSFS IVSLCNHLTR SLMKKVHLRT SEDLRNCESD TEENIARRKA
     LHPRRRSSTS
//
